» Articles » PMID: 34666516

Islet Cell Encapsulation - Application in Diabetes Treatment

Overview
Specialty Biology
Date 2021 Oct 20
PMID 34666516
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In this minireview, we briefly outline the hallmarks of diabetes, the distinction between type 1 and type 2 diabetes, the global incidence of diabetes, and its associated comorbidities. The main goal of the review is to highlight the great potential of encapsulated pancreatic islet transplantation to provide a cure for type 1 diabetes. Following a short overview of the different approaches to islet encapsulation, we provide a summary of the merits and demerits of each approach of the encapsulation technology. We then discuss various attempts to clinical translation with each model of encapsulation as well as the factors that have mitigated the full clinical realization of the promise of the encapsulation technology, the progress that has been made and the challenges that remain to be overcome. In particular, we pay significant attention to the emerging strategies to overcome these challenges. We believe that these strategies to enhance the performance of the encapsulated islet constructs discussed herein provide good platforms for additional work to achieve successful clinical translation of the encapsulated islet technology.

Citing Articles

Immunoprotection Strategies in β-Cell Replacement Therapy: A Closer Look at Porcine Islet Xenotransplantation.

Grimus S, Sarangova V, Welzel P, Ludwig B, Seissler J, Kemter E Adv Sci (Weinh). 2024; 11(31):e2401385.

PMID: 38884159 PMC: 11336975. DOI: 10.1002/advs.202401385.


Encapsulation and immune protection for type 1 diabetes cell therapy.

Kioulaphides S, Garcia A Adv Drug Deliv Rev. 2024; 207:115205.

PMID: 38360355 PMC: 10948298. DOI: 10.1016/j.addr.2024.115205.


Co-transplantation of pancreatic islets and microvascular fragments effectively restores normoglycemia in diabetic mice.

Wrublewsky S, Weinzierl A, Hornung I, Prates-Roma L, Menger M, Laschke M NPJ Regen Med. 2022; 7(1):67.

PMID: 36333332 PMC: 9636251. DOI: 10.1038/s41536-022-00262-3.

References
1.
Schweicher J, Nyitray C, Desai T . Membranes to achieve immunoprotection of transplanted islets. Front Biosci (Landmark Ed). 2014; 19(1):49-76. PMC: 4230297. DOI: 10.2741/4195. View

2.
Lim F, Sun A . Microencapsulated islets as bioartificial endocrine pancreas. Science. 1980; 210(4472):908-10. DOI: 10.1126/science.6776628. View

3.
Wynyard S, Nathu D, Garkavenko O, Denner J, Elliott R . Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation. 2014; 21(4):309-23. DOI: 10.1111/xen.12102. View

4.
Tomei A, Villa C, Ricordi C . Development of an encapsulated stem cell-based therapy for diabetes. Expert Opin Biol Ther. 2015; 15(9):1321-36. PMC: 6329003. DOI: 10.1517/14712598.2015.1055242. View

5.
Soon-Shiong P, Heintz R, Merideth N, Yao Q, Yao Z, Zheng T . Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet. 1994; 343(8903):950-1. DOI: 10.1016/s0140-6736(94)90067-1. View